Vivoryon Therapeutics NV
F:05Y
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
AMN Healthcare Services Inc
NYSE:AMN
|
US |
|
I
|
Iss A/S
F:QJQ
|
DK |
|
Sanlam Ltd
F:LA6A
|
ZA |
|
Hyundai Motor Co
KRX:005380
|
KR |
|
LL Flooring Holdings Inc
OTC:LLFLQ
|
US |
|
U
|
UniCredit SpA
OTC:UNCFF
|
IT |
|
P
|
Primerica Inc
F:PI7
|
US |
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
US |
|
E
|
Elvalhalcor Hellenic Copper and Aluminium Industry SA
ATHEX:ELHA
|
GR |
|
U
|
Ulta Beauty Inc
F:34U
|
US |
|
ESR-REIT
OTC:CGIUF
|
SG |
|
Z
|
Zoom Video Communications Inc
SWB:5ZM
|
US |
|
G
|
Gap Inc
XMUN:GAP
|
US |
|
Cantor Equity Partners Inc
NASDAQ:CEP
|
US |
|
Zimmer Biomet Holdings Inc
NYSE:ZBH
|
US |
|
Compagnie de Saint Gobain SA
PAR:SGO
|
FR |
Bankruptcy Probability
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vivoryon Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Vivoryon Therapeutics NV
AEX:VVY
|
31.7m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vivoryon Therapeutics NV has total debt of 11k EUR. This includes both short-term (0 EUR) and long-term (11k EUR) debt.
You can find a full breakdown on its Balance Sheet.
